Chaperons Protein 10 marker in md pathology rguhs exam
Reading File
Finding Sources
Finding Sources
Searching the Web
Chaperonin 10 HSP10 tumor marker MD pathology RGUHS exam question
Finding Sources
Finding Sources
Searching the Web
Chaperonin 10 HSP10 early pregnancy factor tumor marker pathology
Reading Web Page
Chaperonin 10 HSP10 tumor marker early pregnancy factor pathology
Finding Sources
Now I have comprehensive information to give a thorough, exam-oriented answer. Here it is:
Chaperonin 10 (HSP10) as a Marker - MD Pathology RGUHS
What is Chaperonin 10?
Chaperonin 10 (Cpn10), also called Heat Shock Protein 10 (HSP10), is a small mitochondrial co-chaperone protein (~10 kDa monomer, forms a 70 kDa heptameric ring). It is the co-chaperone of HSP60 (Cpn60), and together they form the HSP60/HSP10 chaperonin system responsible for protein folding inside the mitochondrial matrix.
Structure & Function
| Feature | Detail |
|---|---|
| Gene | HSPE1 (chromosome 2p11.2) |
| Location | Mitochondrial matrix (primarily) |
| Structure | 7-subunit heptameric ring ("lid") capping the HSP60 barrel |
| Function | Assists HSP60 in ATP-dependent correct folding of newly imported mitochondrial proteins; prevents protein misfolding/aggregation |
Chaperonin 10 as the "Early Pregnancy Factor" (EPF) - Key Exam Point
This is the most frequently tested association in pathology exams:
- Early Pregnancy Factor (EPF) was first described in 1977 (Lancet) as an immunosuppressive factor detected in maternal serum within 24-48 hours after fertilization - even before implantation.
- In 1994, EPF was purified from human platelets and identified as Chaperonin 10 (Cavanagh & Morton, Eur J Biochem, 1994).
- EPF/Cpn10 is secreted by trophoblastic cells and acts as an immunomodulator, suppressing maternal immune response to protect the fetus (semi-allograft).
- It forms the basis of a very early pregnancy test (Rosette Inhibition Test / RIT) - can detect pregnancy before HCG-based tests.
- EPF-like activity disappears by week 28-31 of pregnancy.
The Developing Human (Moore & Persaud): "Early pregnancy factor, an immunosuppressant protein, is secreted by trophoblastic cells and appears in maternal serum within 24 to 48 hours after fertilization."
Chaperonin 10 as a Tumor Marker
Overexpression in Cancers
HSP10 is overexpressed in multiple cancers and is being studied as a prognostic biomarker:
| Cancer | Significance |
|---|---|
| Colorectal cancer | Identified as a biomarker by protein profiling; elevated in malignant vs. normal colon tissue |
| Oral Squamous Cell Carcinoma (OSCC) | High HSP10 expression = poor prognosis, lymph node metastasis, treatment resistance |
| Astrocytoma | Elevated HSP10 inhibits apoptosis; associated with poor prognosis |
| Germ cell tumors | EPF-like activity detected; utility as tumor marker post-surgery to assess complete excision |
| Breast, ovarian, gastric cancers | Overexpressed in conjunction with HSP60 |
Mechanism in Cancer
- HSP10 (with HSP60) is mis-localized to the cytosol and cell membrane in cancer cells (normally mitochondrial)
- Detected in blood/serum of cancer patients
- Protects cancer cells from apoptosis
- Linked to NF-kB, WNT/beta-catenin, PI3K/Akt pathways (via HSP60 partnership)
- Anti-apoptotic role: HSP10 overexpression inhibits apoptosis, contributing to tumor survival
Chaperonin 10 in Autoimmune Pathology
- Autoimmune Pancreatitis (AIP): Autoantibodies to HSP10 found in 92% of AIP patients (Henry's Clinical Diagnosis & Management by Laboratory Methods)
- Rheumatoid Arthritis: Recombinant Cpn10 (rCpn10 / XToll) was tested as an immunomodulatory biologic in RA - a Lancet-published RCT showed efficacy (5-10 mg IV twice weekly)
- HSP60 autoantibodies are linked to Takayasu arteritis, atherosclerosis
Summary Table for Quick Revision
| Context | Role of Cpn10 / HSP10 |
|---|---|
| Normal cell | Mitochondrial co-chaperone with HSP60; assists protein folding |
| Early pregnancy | = EPF; immunosuppressant, detected 24-48 hrs post-fertilization (before HCG) |
| Tumor biology | Overexpressed; anti-apoptotic; prognostic marker in OSCC, colorectal, astrocytoma |
| Germ cell tumors | EPF-like activity; used to monitor surgical excision success |
| Autoimmune pancreatitis | Autoantibody target (92% of cases) |
| Therapeutic target | rCpn10 tested in RA (immunomodulation) |
Exam Write-up Tip (RGUHS Format)
When asked about Chaperonin 10 as a marker, cover:
- Definition - HSP10, co-chaperone of HSP60, mitochondrial protein
- Identity with EPF - early pregnancy factor, immunosuppressant, 24-48 hrs post-fertilization
- Mechanism - inhibits maternal immune rejection; detected by Rosette Inhibition Test
- As a tumor marker - overexpressed in colorectal, OSCC, astrocytoma; anti-apoptotic; germ cell tumor monitoring
- In autoimmunity - AIP autoantibody, RA therapy
- Significance - earliest marker of pregnancy; potential cancer biomarker and therapeutic target
Key references for this topic:
- Cavanagh & Morton (1994): identification of EPF as Chaperonin 10
- Henry's Clinical Diagnosis (textbook): HSP10 autoantibodies in 92% of AIP
- The Developing Human (Moore, textbook): EPF secreted by trophoblasts within 24-48 hrs
This is a shared conversation. Sign in to Orris to start your own chat.